Figure 2. Responder Analyses of Categorical Change in Peak Oxygen Uptake (pVO₂) With Aficamten vs Placebo at 24 Weeks.

Data represented as proportion of patients experiencing small (0 to <1.5), moderate (≥1.5 to <3), or large (≥3.0) deteriorations or improvements in pVO₂ (in milliliters per kilogram per minute) per treatment group.